Risposte sanitarie e sociali ai problemi della droga: una guida europea 2021
![](/files/styles/max_325x325/public/2021-10/ERG2021_overview2.jpg?itok=yCV1Egp_)
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'
Obiettivo: dare il via alla serie di webinar sulla cannabis, aprendo il dibattito con una panoramica onnicomprensiva delle questioni chiave e delle opzioni di risposta disponibili.
Antefatti:
Obiettivo: discutere i risultati del rapporto Prison and drugs in Europe: current and future challenges Insights with key customers.
Stakeholder invitati: